032566784	032566784	CD	B-NP	O
|	|	NN	I-NP	O
TDH	TDH	NN	I-NP	O
|	|	NN	I-NP	O
32147963	32147963	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3805858	3805858	CD	B-NP	O
|	|	CC	I-NP	O
9/20/2004	9/20/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Hereditary	Hereditary	NNP	I-NP	O
Angioedema	Angioedema	NNP	I-NP	O
flare	flare	NN	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/28/2004	7/28/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/18/2004	3/18/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
QUATRARO	QUATRARO	NNP	B-NP	O
,	,	,	O	O
BERRY	BERRY	NNP	B-NP	O
T.	T.	NNP	I-NP	O
882-12-27-0	882-12-27-0	CD	I-NP	O
Pa	Pa	NNP	I-NP	O
Ra	Ra	NNP	I-NP	O
Grove	Grove	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/15/04	10/15/04	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
AIPOPO	AIPOPO	NN	B-NP	O
,	,	,	O	O
JAIME	JAIME	NNP	B-NP	O
MILES	MILES	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ATENOLOL	ATENOLOL	NN	B-NP	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DANAZOL	DANAZOL	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
April	April	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
8/19	8/19	CD	B-NP	O
start	start	NN	I-NP	O
regular	regular	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
alternating	alternate	VBG	B-VP	O
200	200	CD	B-NP	O
and	and	CC	I-NP	O
400	400	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
qtues	qtue	NNS	I-NP	O
,	,	,	O	O
thurs	thur	NNS	B-NP	O
,	,	,	O	O
sat	sat	NN	B-NP	O
,	,	,	O	O
sun	sun	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/22/04	5/22/04	CD	B-NP	O
by	by	IN	B-PP	O
MCNIELL	MCNIELL	NNP	B-NP	O
,	,	,	O	O
CASEY	CASEY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	RB	B-PP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.1875	0.1875	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
qmon	qmon	NN	I-NP	O
,	,	,	O	O
wed	wed	VBN	B-NP	O
,	,	,	I-NP	O
friday	friday	JJ	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/22/04	5/22/04	CD	B-NP	O
by	by	IN	B-PP	O
GIRTON	GIRTON	NNP	B-NP	O
,	,	,	O	O
ROCKY	ROCKY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	B-DNA
LASIX	LASIX	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
TID	TID	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
April	April	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
take	take	VB	B-VP	O
per	per	NN	B-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/22/04	5/22/04	CD	B-NP	O
by	by	IN	B-PP	O
SIMMOND	SIMMOND	NNP	B-NP	O
,	,	,	O	O
MONTY	MONTY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	VB	B-VP	O
on	on	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
SYNTHROID	SYNTHROID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/22/04	5/22/04	CD	B-NP	O
by	by	IN	B-PP	O
DORRELL	DORRELL	NN	B-NP	O
,	,	,	O	O
BENNIE	BENNIE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
75786077	75786077	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/22/04	5/22/04	CD	B-NP	O
by	by	IN	B-PP	O
MUTHART	MUTHART	NNP	B-NP	O
,	,	,	O	O
YONG	YONG	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
97216911	97216911	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	RB	B-PP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	B-DNA
ALLEGRA	ALLEGRA	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
FEXOFENADINE	FEXOFENADINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
60	60	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ZANTAC	ZANTAC	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
RANITIDINE	RANITIDINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ASA	ASA	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
81	81	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/15/04	10/15/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
DEFINITE	DEFINITE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
SENNA	SENNA	NN	B-NP	B-protein
TABLETS	TABLETS	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
diarrhea	diarrhea	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Advance	Advance	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
/	/	SYM	I-NP	O
Lactose	Lactose	NN	I-NP	O
Restricted	Restrict	VBN	B-VP	O
/	/	SYM	B-NP	O
wheat	wheat	NN	I-NP	O
restricted	restricted	JJ	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
GI	GI	NN	B-NP	O
after	after	IN	B-PP	O
9/2	9/2	CD	B-NP	O
call	call	NN	I-NP	O
to	to	TO	B-PP	O
schedule	schedule	NN	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Jennrich	Jennrich	NNP	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
appt	appt	NN	B-NP	O
as	as	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
,	,	,	O	O
Allergy/Immunology	Allergy/Immunology	NNP	B-NP	O
doctor	doctor	NN	I-NP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Iv	Iv	NN	B-NP	O
contrast	contrast	NN	I-NP	O
dyes	dye	NNS	I-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Quinidine	Quinidine	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
quinidine	quinidine	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Levofloxacin	Levofloxacin	NNP	B-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
,	,	,	O	O
Quinidine	Quinidine	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
quinidine	quinidine	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Macrodantin	Macrodantin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
nitrofurantoin	nitrofurantoin	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
,	,	,	O	O
Stanazol	Stanazol	NNP	B-NP	O
,	,	,	O	O
Novocain	Novocain	NNP	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
procaine	procaine	NN	I-NP	O
hcl	hcl	NN	I-NP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
Dairy	Dairy	NNP	B-NP	O
products	product	NNS	I-NP	O
,	,	,	O	O
Wheat/gluten	Wheat/gluten	IN	B-PP	O
ADMIT	ADMIT	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hereditary	Hereditary	NNP	I-NP	O
Angioedema	Angioedema	NNP	I-NP	O
flare	flare	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HEREDITARY	HEREDITARY	NNP	I-NP	O
ANGIOEDEMA	ANGIOEDEMA	NNP	I-NP	O
AFIB	AFIB	NNP	I-NP	O
-	-	HYPH	B-NP	O
lodose	lodose	JJ	I-NP	O
Coum/ASA	Coum/ASA	NN	I-NP	O
HYPOTHY	HYPOTHY	NN	I-NP	O
H/O	H/O	NN	I-NP	O
SUBDURAL	SUBDURAL	NN	I-NP	O
ON	ON	NN	I-NP	O
COUM	COUM	NN	I-NP	O
S/P	S/P	NN	I-NP	O
APPY	APPY	NN	I-NP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
tracheostomies	tracheostomy	NNS	I-NP	I-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
multiple	multiple	JJ	I-NP	O
intubations	intubation	NNS	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
ivc	ivc	NN	B-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
GERD	GERD	NN	I-NP	O
polycythemia	polycythemia	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CT	CT	NNP	I-NP	O
abdomen	abdoman	NNS	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
stricture	stricture	NN	B-NP	O
of	of	IN	B-PP	O
descending	descend	VBG	B-VP	O
colon	colon	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82	82	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
long	long	RB	B-ADVP	O
standing	stand	VBG	B-VP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
angioedema	angioedema	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NNP	B-NP	O
reports	report	VBZ	B-VP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
crampy	crampy	JJ	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
with	with	IN	B-PP	O
associated	associate	VBN	B-NP	O
bilious	bilious	JJ	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
angiodedema	angiodedema	NN	I-NP	O
flares	flare	NNS	I-NP	O
.	.	.	O	O

Normally	Normally	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
manages	manage	VBZ	B-VP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
her	her	PRP$	B-NP	O
danazol	danazol	NN	I-NP	O
dose	dose	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
enough	enough	JJ	B-ADJP	O
to	to	TO	B-VP	O
stabilize	stabilize	VB	I-VP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
FFP	FFP	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
helps	help	VBZ	B-VP	O
with	with	IN	B-PP	O
flares	flare	NNS	B-NP	O
by	by	IN	B-PP	O
repleting	replete	VBG	B-VP	O
the	the	DT	B-NP	O
missing	miss	VBG	I-NP	O
complement	complement	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
first	first	JJ	I-NP	O
attack	attack	NN	I-NP	O
was	be	VBD	B-VP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
10	10	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
flares	flare	NNS	I-NP	O
this	this	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
including	include	VBG	B-PP	O
6	6	CD	B-NP	O
admissions	admission	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
3	3	CD	B-NP	O
tracheostomies	tracheostomy	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
for	for	IN	B-PP	O
flares	flare	NNS	B-NP	O
threatening	threaten	VBG	B-VP	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
GI	GI	NN	I-NP	O
complications	complication	NNS	I-NP	O
include	include	VBP	B-VP	O
multiple	multiple	JJ	B-NP	O
scarring/strictures	scarring/stricture	NNS	I-NP	O
-	-	HYPH	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
dilitation	dilitation	NN	I-NP	O
with	with	IN	B-PP	O
GI	GI	NN	B-NP	O
next	next	JJ	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
had	have	VBD	I-VP	O
surgery	surgery	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1994	1994	CD	I-NP	O
-RRB-	-RRB-	IN	B-ADVP	O
She	She	PRP	B-NP	O
thinks	think	VBZ	B-VP	O
her	her	PRP$	B-NP	O
trigger	trigger	NN	I-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
is	be	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	O
stressors	stressor	NNS	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
health	health	NN	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
.	.	.	O	O

GI	GI	NN	B-NP	O
doctor	doctor	NN	I-NP	O
:	:	:	O	O
Rapin	Rapin	NNP	B-NP	O
Rheum/All	Rheum/All	NNP	I-NP	O
:	:	:	O	O
Andrea	Andrea	NNP	B-NP	O
Bilbro	Bilbro	NNP	I-NP	O
PMHx	PMHx	NNP	I-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Diverticulitis	Diverticulitis	NNP	B-NP	O
,	,	,	O	O
Atrial	Atrial	NNP	B-NP	O
Fib	Fib	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
no	no	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
Hypothyroid	Hypothyroid	NNP	I-NP	O
,	,	,	O	O
DVT	DVT	NNP	B-NP	O
,	,	,	O	O
HAE	HAE	NNP	B-NP	O
Meds	Meds	NNP	I-NP	O
:	:	:	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
danazol	danazol	NN	B-NP	O
,	,	,	O	O
synthroid	synthroid	NN	B-NP	O
,	,	,	O	O
allegra	allegra	NN	B-NP	O
,	,	,	O	O
ecasa	ecasa	NN	B-NP	O
,	,	,	O	O
zantac	zantac	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
sulfa	sulfa	NN	B-NP	O
,	,	,	O	O
pcn	pcn	NN	B-NP	O
,	,	,	O	O
levo	levo	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

iv	iv	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
FHx	FHx	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
grandkids	grandkid	NNS	I-NP	O
with	with	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
VS	VS	NN	I-NP	O
:	:	:	O	O
97.9	97.9	CD	B-NP	O
152/84	152/84	CD	I-NP	O
114	114	CD	I-NP	O
14	14	CD	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
irreg	irreg	NN	I-NP	O
irreg	irreg	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
s4	s4	NN	I-NP	O
,	,	,	O	O
cta	cta	NN	B-NP	O
b	b	NN	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
bs	b	NNS	I-NP	O
,	,	,	O	O
distended	distended	JJ	B-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
diffuse	diffuse	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pedal	pedal	JJ	I-NP	B-protein
edema	edema	NN	I-NP	I-protein
Labs	Lab	NNS	I-NP	I-protein
:	:	:	O	O
wbc	wbc	NN	B-NP	O
10.3	10.3	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
with	with	IN	B-PP	O
bandemia	bandemia	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
hct	hct	NN	B-NP	B-DNA
49.6	49.6	CD	I-NP	I-DNA
plt	plt	NN	I-NP	I-DNA
304	304	CD	B-NP	I-DNA
cr	cr	NN	I-NP	I-DNA
1.3	1.3	CD	B-NP	I-DNA
,	,	,	O	O
lipase	lipase	NN	B-NP	O
65	65	CD	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
old	old	JJ	B-NP	O
stricture	stricture	NN	I-NP	O
descending	descend	VBG	B-VP	O
colon	colon	NN	B-NP	O
Hospital	Hospital	NN	I-NP	O
Course	Course	NN	I-NP	O
and	and	CC	O	O
Plan	Plan	NN	B-NP	O
82	82	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
flare	flare	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
HAE	HAE	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
triggered	trigger	VBN	B-VP	O
by	by	IN	B-PP	O
stress	stress	NN	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

HAE	HAE	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
much	much	RB	B-VP	O
improved	improve	VBD	I-VP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
FFP	FFP	NN	B-NP	B-protein
,	,	,	I-NP	O
benadryl	benadryl	NN	I-NP	O
and	and	CC	I-NP	O
demerol	demerol	NN	I-NP	O
.	.	.	O	O

Temporarily	Temporarily	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
her	her	PRP	B-NP	O
danazol	danazol	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
had	have	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
h	h	NN	B-NP	O
er	er	NN	I-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
c1	c1	NN	I-NP	O
inh	inh	NN	I-NP	O
,	,	,	O	O
c4	c4	NN	B-NP	B-protein
,	,	,	O	O
c2	c2	NN	B-NP	B-protein
were	be	VBD	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
localizing	localize	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
bandemia	bandemia	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
her	her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
wbc	wbc	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
monitoring	monitoring	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
HTN	HTN	NN	I-NP	B-protein
.	.	.	O	O

on	on	IN	B-PP	O
Atenolol	Atenolol	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
Afib	Afib	NN	I-NP	O
.	.	.	O	O

not	not	RB	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

Unclear	Unclear	JJ	B-ADJP	O
why	why	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

Should	Should	MD	B-VP	O
discuss	discuss	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
1.3	1.3	CD	I-NP	O
.	.	.	O	O

Normalized	Normalize	VBN	B-VP	O
to	to	TO	B-PP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
pre-renal	pre-renal	JJ	I-NP	O
secondary	secondary	JJ	I-NP	O
to	to	TO	B-PP	O
dehydration	dehydration	NN	B-NP	O
during	during	IN	B-PP	O
flare	flare	NN	B-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
scheduled	schedule	VBN	B-NP	O
dilitation	dilitation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
known	known	JJ	I-NP	O
sricture	sricture	NN	I-NP	O
next	next	IN	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

New	New	JJ	B-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
recurrent	recurrent	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
angioedema	angioedema	NN	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
abdominal	abdominal	JJ	I-NP	O
discomfort/nausea/vomiting	discomfort/nausea/vomiting	NN	I-NP	O
,	,	,	O	O
any	any	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
difficulty	difficulty	NN	I-NP	O
breathing	breathing	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
heart	heart	NN	I-NP	B-protein
palpitations/chest	palpitations/chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Resume	Resume	VB	B-VP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
medications	medication	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
vitamin	vitamin	NN	B-NP	O
c	c	NN	I-NP	O
and	and	CC	O	O
e	e	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-ADJP	O
TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

f/up	f/up	NN	B-NP	O
normal	normal	JJ	I-NP	O
wbc	wbc	NN	I-NP	O
and	and	CC	I-NP	O
bandemia	bandemia	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
8	8	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	B-PP	O
not	not	RB	I-PP	O
on	on	IN	B-PP	O
anti-coagulation	anti-coagulation	NN	B-NP	O
.	.	.	O	O
?	?	.	O	O

is	be	VBZ	B-VP	O
she	she	PRP	B-NP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
known	know	VBN	B-VP	O
subdural	subdural	JJ	B-ADJP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

relative	relative	JJ	B-NP	O
contraindication	contraindication	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

f/up	f/up	NN	B-NP	O
complement	complement	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MEBANE	MEBANE	NNP	B-NP	O
,	,	,	O	O
JIMMIE	JIMMIE	NNP	B-NP	O
WARREN	WARREN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BJ53	BJ53	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/15/04	10/15/04	CD	I-NP	O
@	@	SYM	O	O
01	01	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

